Medicare Enrolled
Dr. Sudarshan Velpari
Internal Medicine · Jersey City, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Velpari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Velpari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Velpari
Dr. Sudarshan Velpari is an internal medicine specialist in Jersey City, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Velpari performed 1,959 Medicare services across 922 unique beneficiaries.
Between the years covered by Open Payments, Dr. Velpari received a total of $18,837 from 59 pharmaceutical and/or device companies across 1393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Velpari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 23% volume in NJ
$18,837 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,959
Medicare services
Top 23% in NJ for internal medicine
922
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~122 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
589 | $86 | $257 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
515 | $90 | $330 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
181 | $100 | $291 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
100 | $156 | $469 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
83 | $86 | $226 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
77 | $10 | $48 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
58 | $142 | $320 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
53 | $97 | $300 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
53 | $34 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
49 | $72 | $146 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
47 | $126 | $376 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
41 | $181 | $472 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $67 | $198 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
34 | $103 | $378 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
19 | $149 | $474 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $178 | $472 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $102 | $577 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,837
Total received (2018-2024)
Avg $2,691/year across 7 years
Top 3% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,393
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,837 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,081
2023
$2,765
2022
$2,733
2021
$2,484
2020
$2,232
2019
$3,121
2018
$2,421
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$693
ABBVIE INC.
$414
Corcept Therapeutics
$254
Lilly USA, LLC
$241
Bayer Healthcare Pharmaceuticals Inc.
$230
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$167
Paratek Pharmaceuticals, Inc.
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$146
Exact Sciences Corporation
$117
Abbott Laboratories
$94
Amgen Inc.
$92
Mylan Specialty L.P.
$88
SCILEX PHARMACEUTICALS INC.
$84
PFIZER INC.
$65
Novo Nordisk Inc
$49
SANOFI-AVENTIS U.S. LLC
$44
Takeda Pharmaceuticals U.S.A., Inc.
$31
GlaxoSmithKline, LLC.
$31
Mannkind Corporation
$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
Janssen Pharmaceuticals, Inc
$17
Otsuka America Pharmaceutical, Inc.
$14
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,770
Novo Nordisk Inc
$2,050
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,050
SANOFI-AVENTIS U.S. LLC
$930
Boehringer Ingelheim Pharmaceuticals, Inc.
$856
Janssen Pharmaceuticals, Inc
$827
ABBVIE INC.
$702
GlaxoSmithKline, LLC.
$658
Amarin Pharma Inc.
$649
Amgen Inc.
$637
Lilly USA, LLC
$634
AbbVie Inc.
$586
Merck Sharp & Dohme Corporation
$518
Allergan Inc.
$454
Paratek Pharmaceuticals, Inc.
$452
Bayer Healthcare Pharmaceuticals Inc.
$437
Takeda Pharmaceuticals U.S.A., Inc.
$412
Merck Sharp & Dohme LLC
$342
Allergan, Inc.
$340
Mannkind Corporation
$336
Corcept Therapeutics
$269
MannKind Corporation
$264
Mylan Specialty L.P.
$247
Bayer HealthCare Pharmaceuticals Inc.
$234
Exact Sciences Corporation
$216
ARBOR PHARMACEUTICALS, INC.
$205
PFIZER INC.
$201
Scilex Pharmaceuticals Inc.
$196
SCILEX PHARMACEUTICALS INC.
$139
Abbott Laboratories
$132
Daiichi Sankyo Inc.
$127
Horizon Therapeutics plc
$114
Novartis Pharmaceuticals Corporation
$73
EISAI INC.
$72
Genentech USA, Inc.
$70
Biohaven Pharmaceuticals, Inc.
$69
Almatica Pharma LLC
$62
Endo Pharmaceuticals Inc.
$59
Gilead Sciences, Inc.
$55
IDORSIA PHARMACEUTICALS US INC
$45
Vanda Pharmaceuticals Inc.
$42
Teva Pharmaceuticals USA, Inc.
$31
BioDelivery Sciences International, Inc.
$29
SANOFI PASTEUR INC.
$27
Astellas Pharma US Inc
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
Biohaven Pharmaceutical Holding Company Ltd.
$16
Nabriva Therapeutics, plc
$15
Avanir Pharmaceuticals, Inc.
$15
Lundbeck LLC
$14
Esperion Therapeutics, Inc.
$14
Eisai Inc.
$14
Otsuka America Pharmaceutical, Inc.
$14
Lupin Inc.
$14
AbbVie, Inc.
$13
Purdue Pharma L.P.
$13
Boston Scientific Corporation
$13
IBSA Pharma Inc.
$11
Sanofi Pasteur Inc.
$11
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ADACEL · ADVAIR · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AUSTEDO · Aimovig · Amitiza · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRINTELLIX · BYSTOLIC · Belviq · CAPLYTA · CHANTIX · CYCLOSET · CYLTEZO · Cologuard Collection Kit · Creon · DIABETES - DISEASE · Dayvigo · Dymista · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Esperoct · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GENERAL PAIN MANAGEMENT · GRALISE · HETLIOZ · Horizant · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LINZESS · LOKELMA · LOREEV XR · LYRICA · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · NAPRELAN · NASCOBAL · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · Otezla · Ozempic · PAXLOVID · PREVNAR - 13 · Prolia · QULIPTA · QUVIVIQ · RELISTOR ORAL · REXULTI · RINVOQ · RYBELSUS · Repatha · Rybelsus · SKYRIZI · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUPRAX · SYMBICORT · SYMPROIC · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TZIELD · Tirosint · Tresiba · Trintellix · UBRELVY · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · Xenleta · Xofluza · Xultophy 100/3.6 · YUPELRI · Yupelri · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
10,926
Per 100K population
1537.8
County median income
$90,032
Nearest hospital
JERSEY CITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Velpari is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NJ), with low-engagement industry engagement in the top 3% of NJ peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Velpari experienced with nursing facility visit, moderate complexity?
Based on Medicare claims data, Dr. Velpari performed 589 nursing facility visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Velpari receive payments from pharmaceutical companies?
Yes. Dr. Velpari received a total of $18,837 from 59 companies across 1,393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Velpari's costs compare to other internal medicine physicians in Jersey City?
Dr. Velpari's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Velpari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Jersey City
Browse internal medicine physicians in Jersey City ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology